Randomized Safety Study of CVT-301 Compared to an Observational Control Group
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
This study is a 12-month, open-label, randomized, multicenter study which will evaluate the
safety and efficacy of CVT-301 for the treatment of up to 5 OFF episodes per day in
Parkinson's Disease (PD) patients experiencing motor fluctuations (OFF episodes) and will
include a concurrent observational cohort of PD patients managed using the usual standards of
care.